Bryan Faust was previously an investing partner on the bio and health team at VC firm Andreessen Horowitz.
Bryan Faust has joined Roche Venture Fund, the startup investment arm of pharmaceutical company Roche, as investment director.
Faust was previously an investing partner on the bio and health team at VC firm Andreessen Horowitz. Prior to that, he spent time as an investment fellow at 5AM Ventures while completing his PhD in biophysics from the University of California, San Francisco (UCSF).
Roche Venture Fund is a financially driven, CHF 750M ($920m) evergreen fund targeting innovative, early-stage (seed through series B) companies across therapeutics, diagnostics and health tech.
See all the recent deals by Roche Venture Fund in the CVC Funding Round Database
Oishani Mitra
Oishani Mitra is the content manager for Global Corporate Venturing.
